2616
COM:CSTONEPHARMA
CStone Pharmaceuticals Co Ltd
- Stock
Last Close
1.96
25/11 03:32
Market Cap
1.57B
Beta: -
Volume Today
1.52M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Sep '18 | Dec '18 | Mar '21 | Jun '21 | Sep '21 | Dec '21 | Mar '22 | Jun '22 | Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | Mar '24 | Jun '24 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 39.72M - | 39.72M 0% | 82.13M 106.76% | 82.13M 0% | 130.88M 59.35% | 130.88M 0% | 109.80M 16.11% | 109.80M 0% | 130.74M 19.07% | 130.74M 0% | 101.18M 22.60% | 101.18M 0% | 127.08M 25.60% | 127.08M 0% | ||||
cost of revenue | 15.61M - | 15.61M 0% | 37.81M 142.25% | 37.81M 0% | 46.36M 22.62% | 46.36M 0% | 55.13M 18.92% | 55.13M 0% | 54.02M 2.02% | 54.02M 0% | 25.75M 52.32% | 25.75M 0% | 41.07M 59.46% | 41.07M 0% | ||||
gross profit | 24.12M - | 24.12M 0% | 44.33M 83.80% | 44.33M 0% | 84.52M 90.68% | 84.52M 0% | 54.67M 35.32% | 54.67M 0% | 76.72M 40.34% | 76.72M 0% | 75.43M 1.68% | 75.43M 0% | 86.01M 14.03% | 86.01M 0% | ||||
selling and marketing expenses | 66.79M - | 66.79M 0% | 115.10M 72.33% | 115.10M 0% | 73.18M 36.43% | 73.18M 0% | 90.47M 23.64% | 90.47M 0% | 65.72M 27.36% | 65.72M 0% | 33.95M 48.34% | 33.95M 0% | 31.38M 7.56% | 31.38M 0% | ||||
general and administrative expenses | 11.87M - | 111.94M 843.25% | -42.80M 138.24% | 76.21M 278.06% | 76.21M 0% | 71.35M 6.37% | 71.35M 0% | 67.12M 5.93% | 67.12M 0% | 55.88M 16.75% | 55.88M 0% | 43.85M 21.52% | 43.85M 0% | 47.51M 8.35% | 47.51M 0% | 22.59M 52.46% | 22.59M 0% | |
selling general and administrative expenses | 11.87M - | 111.94M 843.25% | -42.80M 138.24% | 143.84M 436.09% | 143.84M 0% | 186.85M 29.90% | 186.85M 0% | 140.59M 24.76% | 140.59M 0% | 147.60M 4.99% | 147.60M 0% | 110.32M 25.26% | 110.32M 0% | 80.71M 26.83% | 80.71M 0% | 54.72M 32.20% | 54.72M 0% | |
research and development expenses | 47.61M - | 190.56M 300.26% | 150.90M 20.81% | 256.38M 69.89% | 256.38M 0% | 396.10M 54.50% | 396.10M 0% | 133.31M 66.34% | 133.31M 0% | 173.77M 30.35% | 173.77M 0% | 93.39M 46.26% | 93.39M 0% | 170.51M 82.59% | 170.51M 0% | 33.12M 80.57% | 33.12M 0% | |
other expenses | -10.30M - | -25.04M 143.08% | 130.25M 620.24% | |||||||||||||||
cost and expenses | 49.18M - | 277.46M 464.22% | 238.36M 14.09% | 429.05M 80.00% | 429.05M 0% | 656.64M 53.04% | 656.64M 0% | 310.98M 52.64% | 310.98M 0% | 381.64M 22.72% | 381.64M 0% | 240.11M 37.09% | 240.11M 0% | 169.52M 29.40% | 169.52M 0% | 128.91M 23.96% | 128.91M 0% | |
operating expenses | 49.18M - | 277.46M 464.22% | 238.36M 14.09% | 413.44M 73.46% | 413.44M 0% | 618.83M 49.68% | 618.83M 0% | 264.62M 57.24% | 264.62M 0% | 326.51M 23.39% | 326.51M 0% | 186.09M 43.01% | 186.09M 0% | 143.77M 22.74% | 143.77M 0% | 87.84M 38.90% | 87.84M 0% | |
interest expense | 6.22M - | 6.64M - | ||||||||||||||||
ebitda | -55.09M - | 132.68M 340.86% | -576.53M 534.54% | -373.23M 35.26% | -373.23M 0% | -537.11M 43.91% | -537.11M 0% | -184.67M 65.62% | -184.67M 0% | -263.04M 42.44% | -263.04M 0% | -122.13M 53.57% | -122.13M 0% | -170.56M 39.65% | -170.56M 0% | 1.61M 100.94% | 1.61M 0% | |
operating income | -55.49M - | 132.68M 339.09% | -577.94M 535.60% | -376.10M 34.92% | -376.10M 0% | -538.62M 43.21% | -538.62M 0% | -189.38M 64.84% | -189.38M 0% | -266.70M 40.83% | -266.70M 0% | -126.98M 52.39% | -126.98M 0% | -175.80M 38.44% | -175.80M 0% | -1.83M 98.96% | -1.83M 0% | |
depreciation and amortization | 407K - | 1.41M - | 2.88M 103.57% | 2.88M 0% | 1.50M 47.73% | 1.50M 0% | 4.71M 213.20% | 4.71M 0% | 3.66M 22.26% | 3.66M 0% | 4.85M 32.57% | 4.85M 0% | 5.24M 8.00% | 5.24M 0% | 3.44M 34.36% | 3.44M 0% | ||
total other income expenses net | -13.53M - | -550.82M 3,969.86% | -52.79M 90.42% | -10.82M 79.50% | -10.82M 0% | -34.51M 218.87% | -34.51M 0% | 8.59M 124.90% | 8.59M 0% | -3.86M 144.90% | -3.86M 0% | 22.37M 679.77% | 22.37M 0% | 96.80M 332.69% | 96.80M 0% | 9.68M 90.00% | 9.68M 0% | |
income before tax | -69.03M - | -418.14M 505.77% | -630.73M 50.84% | -386.93M 38.65% | -386.93M 0% | -573.12M 48.12% | -573.12M 0% | -180.78M 68.46% | -180.78M 0% | -270.55M 49.66% | -270.55M 0% | -104.61M 61.33% | -104.61M 0% | -79.00M 24.48% | -79.00M 0% | 7.85M 109.94% | 7.85M 0% | |
income tax expense | 6.72M - | 529.59M 7,778.43% | 52.79M 90.03% | 5 - | 2 - | |||||||||||||
net income | -75.75M - | -947.73M 1,151.16% | -683.52M 27.88% | -386.93M 43.39% | -386.93M 0% | -573.12M 48.12% | -573.12M 0% | -180.78M 68.46% | -180.78M 0% | -270.55M 49.66% | -270.55M 0% | -104.61M 61.33% | -104.61M 0% | -79.00M 24.48% | -79.00M 0% | 7.85M 109.94% | 7.85M 0% | |
weighted average shs out | 984.05M - | 984.05M 0% | 984.05M 0% | 1.15B 17.35% | 1.15B 0% | 1.17B 1.57% | 1.17B 0% | 1.17B 0.56% | 1.17B 0% | 1.17B 0.26% | 1.17B 0% | 1.23B 5.25% | 1.23B 0% | 1.28B 4.07% | 1.28B 0% | 1.57B 22.57% | 1.57B 0% | |
weighted average shs out dil | 984.05M - | 984.05M 0% | 984.05M 0% | 1.15B 17.35% | 1.15B 0.00% | 1.18B 1.80% | 1.18B 0% | 1.18B 0.06% | 1.18B 0% | 1.17B 0.59% | 1.17B 0% | 1.25B 7.05% | 1.25B 0% | 1.28B 2.32% | 1.28B 0% | 1.28B 0.42% | 1.28B 0% | |
eps | -0.08 - | -0.96 1,146.75% | -0.69 28.13% | -0.34 50.72% | -0.34 0% | -0.49 44.12% | -0.49 0% | -0.16 67.35% | -0.16 0% | -0.23 43.75% | -0.23 0% | -0.09 63.04% | -0.09 0% | -0.06 27.41% | -0.06 0% | 0.01 108.10% | 0.01 0% | |
epsdiluted | -0.08 - | -0.96 1,146.75% | -0.69 28.13% | -0.34 50.72% | -0.34 0% | -0.49 44.12% | -0.49 0% | -0.15 69.39% | -0.15 0% | -0.23 53.33% | -0.23 0% | -0.08 63.65% | -0.08 0% | -0.06 26.20% | -0.06 0% | 0.01 110.05% | 0.01 0% |
All numbers in (except ratios and percentages)